Idarubicin Hydrochloride and Succinylcholine Chloride

• Generic Name: idarubicin
• Dosage Forms: n.a.
• Other Brand Names: Idamycin PFS, Idamycin

Used in combination with other antineoplastic agents for the treatment of acute myeloid (myelogenous, nonlymphocytic) leukemia (AML), including French-American-British classifications M1 through M7.

Regimen consisting of cytarabine with either daunorubicin or idarubicin is a regimen of choice for remission induction in AML.

Used in combination with cytarabine for the treatment of recurrent or refractory AML.

• Generic Name: succinylcholine
• Dosage Forms: n.a.
• Other Brand Names: Anectine, Quelicin

Production of skeletal muscle relaxation during procedures of short duration (e.g., endotracheal intubation) after general anesthesia has been induced; neuromuscular blocking agent of choice for procedures lasting <3 minutes.

Facilitation of endotracheal intubation; because of its rapid onset and short duration of action, generally considered neuromuscular blocking agent of choice in emergency situations when rapid intubation (e.g., rapid sequence intubation) is required.

Also used to facilitate mechanical ventilation; however, not used for prolonged neuromuscular blockade in the ICU.

Because of serious adverse effects, restrict use in pediatric population. (See Boxed Warning.)